Illuma currently serves a spectrum of several client companies providing assistance with financing, corporate strategy and messaging, pipeline planning, diligence, operations, regulatory, clinical development, CMC, nonclinical studies and drug discovery. Our current clients span a range of therapeutic and diagnostic areas including cancer, fibrosis, immunology and inflammatory conditions. Our Leadership: Dr. Eric Springman, President During his 25-year industry career, Dr Springman has brought many new investigational medicines from discovery to clinic in disease conditions ranging from inflammation and fibrosis to osteoporosis and cancer. He completed his postdoctoral training in Clinical Pharmacology and Immunology at Vanderbilt University School of Medicine, where he was an American Lung Association Research Fellow. He holds a PhD in Molecular Biophysics from Florida State University, where his graduate work was presented at the 1998 Nobel Mini-Forum. Dr Springman is a past member of the Pennsylvania Drug, Device and Cosmetics Board and the GABIO Board of Directors. He currently serves on Scientific Research Committee of Vibliome Therapeutics
